Buscar resultados de ensayos clínicos

Patrocinado por

Carcinoma, Intraductal, Noninfiltrating - 6 Studies Found

Estado Estudiar
Active, not recruiting Nombre del estudio: Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS)
Condición: Carcinoma, Intraductal, Noninfiltrating
Fecha: 2016-08-10
Intervenciones: Drug: Pembrolizumab Other Names:
  • Keytruda
  • MK-3475
Completed Nombre del estudio: Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Condición:
  • Carcinoma, Intraductal, Noninfiltrating
  • DCIS
  • Drug: Chloroquine Standard Dose (500mg/week)

Completed Nombre del estudio: Women Informed to Screen Depending on Measures of Risk
Condición:
  • Breast Neoplasms
  • Carcinoma, Intraductal, Noninfiltrating
    • <
    Fecha: 2015-12-01
    Intervenciones:
    • Other: Complete a health questionnaire

Not yet recruiting Nombre del estudio: Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Condición: Breast Cancer
Fecha: 2008-11-07
Intervenciones:
  • Drug: vorinostat
  • Genetic: protein expressi
Completed Nombre del estudio: Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Condición: Ductal Carcinoma in Situ
Fecha: 2011-06-09
Intervenciones: Drug: SOM 230 / Pasireotide SOM230/Pasireotide is a multi-receptor targeted somatostatin analogue. In th
Terminated Nombre del estudio: Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Condición: Breast Cancer
Fecha: 2006-02-09
Intervenciones:
  • Drug: Tamoxifen Tamoxifen may